인바이오

352940KOSDAQ비료, 농약 및 살균, 살충제 제조업

45.8 / 100

Reference Date: 2026-07-24

Financial Score12.5 / 40

News Sentiment21.3 / 25

Momentum5.0 / 20

Disclosure7.0 / 15

AI Analysis: PBR is undervalued vs. peers but ROE is below the industry average. Roughly flat over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Inbio produces and sells multifunctional pesticides, herbicides, and eco-friendly crop protection products, developing combined formulations to reduce farmers' workload and increase agricultural income. Responding to rising demand for labor-saving combined products, the company invests in R&D to differentiate its offerings through enhanced efficacy and user convenience, driving market growth.

Number of Employees

158people

Average Salary

44.2M KRW

Score Calculation Basis

Detailed Financial Score

PER

21.67Industry Average 11.771.5Point

1.8x industry avg (risky)

PBR

0.52Industry Average 0.534.0Point

In line with industry avg

ROE

2.41Industry Average 4.322.5Point

Below industry avg

Debt Ratio

12.23Industry Average 7.870.5Point

1.6x industry avg (risky)

Trend 2023~20254.0 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲0.0% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲53.6% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -3.5% (improving, 3yr)

Detailed News Sentiment

2 totalPositive 2Neutral 0Negative 0Average Sentiment Score 85

Positive
인바이오, 내년 자사주 매입 본격화…200억 규모 재원 확보
인바이오가 내년부터 대규모 자사주 매입을 통해 주주 가치를 증대시키는 계획을 발표하여 긍정적인 시장 반응을 이끌어냈다.
Positive
인바이오, 발행주식 10% 수준의 자기주식 매입
인바이오의 자기주식 매입 계획 발표로 주당 가치 상승 기대 증가.

Detailed Momentum

52-week position1.0Point

Near 52w low (6%, downtrend)

Current 2,015Won52-week high 2,47052-week low 1,984

1-month return3.0Point

1m -0.49% (flat)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

8 totalPositive 0Neutral 7Negative 1

Neutral대표이사변경2026-07-23
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-21
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-07
Neutral[기재정정]본점소재지변경2026-06-30
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-30